ConductScience.org, home

Paper8367455

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

Lisziewicz J and 9 others. Proc Natl Acad Sci U S A, 1993. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Papers, record 8367455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8367455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
2.26
iCite
Revised in PubMed
2019-05-01
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lisziewicz JJ
2Sun DD
3Smythe JJ
4Lusso PP
5Lori FF
6Louie AA
7Markham PP
8Rossi JJ
9Reitz MM
10Gallo RCR C

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acquired Immunodeficiency SyndromeMajor topic
Bacterial ProteinsMajor topic
Escherichia coli ProteinsMajor topic
Gene Products, tatMajor topic
Genetic TherapyMajor topic
HIV-1Major topic
Membrane ProteinsMajor topic
RNA, CatalyticMajor topic
RNA, ViralMajor topic
Receptors, Cell SurfaceMajor topic
Simian Immunodeficiency VirusMajor topic
Virus ReplicationMajor topic
Animals
Cell Line
Chemoreceptor Cells
Genes, gag
HIV Long Terminal Repeat
Humans
In Situ Hybridization
Plasmids
Restriction Mapping
T-Lymphocytes
Transfection
tat Gene Products, Human Immunodeficiency Virus

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12831375A safe packaging line for gene transfer: separating viral genes on two different plasmids.J Virol1988https://conductscience.org/library/papers/2831375PubMed
22825351Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.Science1987https://conductscience.org/library/papers/2825351PubMed
32536828Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.J Virol1989https://conductscience.org/library/papers/2536828PubMed
42542934Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2542934PubMed
52478293Tat trans-activates the human immunodeficiency virus through a nascent RNA target.Cell1989https://conductscience.org/library/papers/2478293PubMed
62184372Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.Nature1990https://conductscience.org/library/papers/2184372PubMed
72225067Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.Cell1990https://conductscience.org/library/papers/2225067PubMed
82227414A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.Genes Dev1990https://conductscience.org/library/papers/2227414PubMed
91848369An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.Science1991https://conductscience.org/library/papers/1848369PubMed
102562188The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain.New Biol1989https://conductscience.org/library/papers/2562188PubMed
112039768Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.New Biol1991https://conductscience.org/library/papers/2039768PubMed
121646840Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection.J Immunol1991https://conductscience.org/library/papers/1646840PubMed
131589762Human gene therapy.Science1992https://conductscience.org/library/papers/1589762PubMed
141608446Human gene therapy comes of age.Nature1992https://conductscience.org/library/papers/1608446PubMed
151321271Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.J Virol1992https://conductscience.org/library/papers/1321271PubMed
161279199Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.J Virol1992https://conductscience.org/library/papers/1279199PubMed
178416373Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.J Virol1993https://conductscience.org/library/papers/8416373PubMed
182988790The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.Cell1985https://conductscience.org/library/papers/2988790PubMed
192990040Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).Science1985https://conductscience.org/library/papers/2990040PubMed
202435942Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.J Natl Cancer Inst1987https://conductscience.org/library/papers/2435942PubMed

See all 22 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
32288940Molecular recognition elements: DNA/RNA-aptamers to proteins.Biochem Mosc Suppl B Biomed Chem2010https://conductscience.org/library/papers/32288940PubMed
26079406Cell-based gene therapy against HIV.Gene Ther2015https://conductscience.org/library/papers/26079406PubMed
25636849Inducible suppression of global translation by overuse of rare codons.Appl Environ Microbiol2015https://conductscience.org/library/papers/25636849PubMed
23028130Novel cell and gene therapies for HIV.Cold Spring Harb Perspect Med2012https://conductscience.org/library/papers/23028130PubMed
20737298The use of cell-delivered gene therapy for the treatment of HIV/AIDS.Immunol Res2010https://conductscience.org/library/papers/20737298PubMed
17565699Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.Retrovirology2007https://conductscience.org/library/papers/17565699PubMed
16109172CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.Retrovirology2005https://conductscience.org/library/papers/16109172PubMed
15813990HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.AIDS Res Ther2005https://conductscience.org/library/papers/15813990PubMed
15813986Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages.AIDS Res Ther2004https://conductscience.org/library/papers/15813986PubMed
12376617A nucleolar TAR decoy inhibitor of HIV-1 replication.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12376617PubMed
11907228Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits human immunodeficiency virus type 1 production.J Virol2002https://conductscience.org/library/papers/11907228PubMed
11438838SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.Gene Ther2001https://conductscience.org/library/papers/11438838PubMed
11368355Gene therapy: principles and applications to hematopoietic cells.Leukemia2001https://conductscience.org/library/papers/11368355PubMed
11287684Gene therapy for HIV.Sex Transm Infect2001https://conductscience.org/library/papers/11287684PubMed
10931921Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.Nucleic Acids Res2000https://conductscience.org/library/papers/10931921PubMed
10694813Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.Gene Ther2000https://conductscience.org/library/papers/10694813PubMed
10400815Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.J Virol1999https://conductscience.org/library/papers/10400815PubMed
10233987Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy.J Virol1999https://conductscience.org/library/papers/10233987PubMed
9722635RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.Nucleic Acids Res1998https://conductscience.org/library/papers/9722635PubMed
9611232TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer.Nucleic Acids Res1998https://conductscience.org/library/papers/9611232PubMed

See all 38 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
RBM8A9939PubTator's text mininghttps://conductscience.org/library/genes/9939NCBI Gene
TAT6898PubTator's text mininghttps://conductscience.org/library/genes/6898NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8367455

GET https://conductscience.org/api/papers/v1/8367455/references?page=2